# active_site_0080

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **D** — Position 146 (Proton acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MGPANSEGTMFDAFSREVGDYYDQANELLRAMFTDNVHYGYWPDPSSIDPLAEAGERMTEQLYERLDVSAGHKVLDVGCGVGKPAAWLARKTGATVKGANVSRNQLEVARDRVRSEGLEDRVSFDLADAMHLPYADDSFDRIWAIESMIHMPDRDQVMREMARVLRPGGRLAIADIVVRGTLDDVATAVVEGFCTLSTARSLEHIDNYPALVEKAGLDLLELTDVSEQTRPTGPAVLPAFDVLLPTLGEEGVAQSKKAWGDMFDLPQYGYVLLTAGKP

[Multiple Choices]
A. Position 112 (Nucleophile)
B. Position 286 (Charge relay system)
C. Position 957 (Proton acceptor; for dehydratase activity)
D. Position 146 (Proton acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record, which annotates residue 146 as the active-site proton acceptor. The annotation cites a publication whose record also notes mutagenesis of Glu-146. This supports D, though the supplied excerpts do not independently establish the experimental result.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence identifies residue 146 as glutamate, which is chemically capable of acting as a proton acceptor, but that plausibility does not distinguish it as the catalytic residue from other possible residues.


**Missing item-specific fact**

> The protein-specific functional annotation or experimental evidence identifying Glu-146 as the proton acceptor is absent from the question input.


**Reason**

> The exact catalytic role and position require protein-specific knowledge; sequence chemistry alone does not establish which residue performs that role.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The provided evidence supports D. Choices B and C give positions beyond the 278-residue sequence, and no evidence supports the other listed catalytic assignments.


### Important caveats

- The active-site annotation is manually attributed to a cited publication (ECO:0000305); the excerpts do not provide the paper's results for independent assessment.
- The sequence match establishes source applicability, but the exact historical source snapshot used by the question author is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence identifies residue 146 as glutamate, which is chemically capable of acting as a proton acceptor, but that plausibility does not distinguish it as the catalytic residue from other possible residues.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation or experimental evidence identifying Glu-146 as the proton acceptor is absent from the question input.",
    "reason": "The exact catalytic role and position require protein-specific knowledge; sequence chemistry alone does not establish which residue performs that role."
  },
  "case_id": "active_site_0080",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which annotates residue 146 as the active-site proton acceptor. The annotation cites a publication whose record also notes mutagenesis of Glu-146. This supports D, though the supplied excerpts do not independently establish the experimental result."
  },
  "important_caveats": [
    "The active-site annotation is manually attributed to a cited publication (ECO:0000305); the excerpts do not provide the paper's results for independent assessment.",
    "The sequence match establishes source applicability, but the exact historical source snapshot used by the question author is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The provided evidence supports D. Choices B and C give positions beyond the 278-residue sequence, and no evidence supports the other listed catalytic assignments."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0080",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which annotates residue 146 as the active-site proton acceptor. The annotation cites a publication whose record also notes mutagenesis of Glu-146. This supports D, though the supplied excerpts do not independently establish the experimental result.",
    "evidence_ids": ["C5", "H4", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence identifies residue 146 as glutamate, which is chemically capable of acting as a proton acceptor, but that plausibility does not distinguish it as the catalytic residue from other possible residues.",
    "missing_item_specific_fact": "The protein-specific functional annotation or experimental evidence identifying Glu-146 as the proton acceptor is absent from the question input.",
    "reason": "The exact catalytic role and position require protein-specific knowledge; sequence chemistry alone does not establish which residue performs that role."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The provided evidence supports D. Choices B and C give positions beyond the 278-residue sequence, and no evidence supports the other listed catalytic assignments."
  },
  "important_caveats": [
    "The active-site annotation is manually attributed to a cited publication (ECO:0000305); the excerpts do not provide the paper's results for independent assessment.",
    "The sequence match establishes source applicability, but the exact historical source snapshot used by the question author is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation for E0D208 (Methyltransferase GfsG) explicitly lists an Active site at position 146 described as 'Proton acceptor' with experimental evidence (ECO:0000305|PubMed:26630077), corroborated by mutagenesis studies of Glu-146, His-150, and Asp-175. The sequence at position 146 is Glu (E), consistent with a proton-acceptor role in methyltransferase catalysis. Choices B (position 286) and C (position 957) are impossible since the protein is only 278 residues long. Choice A (position 112, Nucleophile) does not correspond to any annotated active site feature.

Citations as saved: [C5](#evidence-c5), [C9](#evidence-c9), [H4](#evidence-h4), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Three independent reasoning steps distinguish the answer: (1) The protein is 278 residues long, so positions 286 (B) and 957 (C) are physically impossible and can be eliminated by arithmetic. (2) Reading the sequence, position 112 is Arginine (R), which is not a catalytic nucleophile in any common enzyme mechanism; its side-chain guanidinium group is protonated at physiological pH and serves structural/binding roles. Position 146 is Glutamate (E), a classic proton acceptor. (3) The SAM-binding motif (VLDVGCGVG at ~positions 74–82) identifies this as a methyltransferase; in O/C-methyltransferase catalysis, a Glu or Asp proton acceptor deprotonates the substrate hydroxyl to generate the nucleophile that attacks the methyl group of SAM. The enzyme residue itself is not the nucleophile—the substrate is. Thus 'Proton acceptor at a Glu' is mechanistically consistent, while 'Nucleophile at an Arg' is not.


**Missing item-specific fact**

> None critical. The specific position number (146) could be identified by locating the Glu within the SAM-binding region, but the functional description 'Proton acceptor' vs 'Nucleophile' and the residue identity at each position are derivable from the sequence plus general biochemistry.


**Reason**

> The model can eliminate two choices by protein length, then use amino-acid chemistry (Arg ≠ nucleophile; Glu = proton acceptor) and general methyltransferase mechanism knowledge to select D over A. No protein-specific database lookup is strictly required.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> B and C are eliminated by sequence length. A is eliminated because position 112 is Arg, which is not a nucleophile, and methyltransferase mechanisms do not feature an enzyme-side nucleophile at that position. Only D is consistent with both the residue identity (Glu) and the catalytic mechanism.


### Important caveats

- The UniProt annotation for the active site carries evidence code ECO:0000305 (inferred from PubMed:26630077 mutagenesis data), meaning it is experimentally informed but the 'Proton acceptor' label itself is a curator-assigned functional description rather than a directly measured quantity.
- The reviewer-only evidence confirms the sequence match (SHA-256 identical across current and historical entries), so the annotation applies to the exact sequence provided.
- The protein is classified as EC 2.1.1.- (unspecified methyltransferase); the exact substrate and reaction are not fully characterized, but the Glu-146 proton-acceptor role is supported by mutagenesis data.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Three independent reasoning steps distinguish the answer: (1) The protein is 278 residues long, so positions 286 (B) and 957 (C) are physically impossible and can be eliminated by arithmetic. (2) Reading the sequence, position 112 is Arginine (R), which is not a catalytic nucleophile in any common enzyme mechanism; its side-chain guanidinium group is protonated at physiological pH and serves structural/binding roles. Position 146 is Glutamate (E), a classic proton acceptor. (3) The SAM-binding motif (VLDVGCGVG at ~positions 74–82) identifies this as a methyltransferase; in O/C-methyltransferase catalysis, a Glu or Asp proton acceptor deprotonates the substrate hydroxyl to generate the nucleophile that attacks the methyl group of SAM. The enzyme residue itself is not the nucleophile—the substrate is. Thus 'Proton acceptor at a Glu' is mechanistically consistent, while 'Nucleophile at an Arg' is not.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. The specific position number (146) could be identified by locating the Glu within the SAM-binding region, but the functional description 'Proton acceptor' vs 'Nucleophile' and the residue identity at each position are derivable from the sequence plus general biochemistry.",
    "reason": "The model can eliminate two choices by protein length, then use amino-acid chemistry (Arg ≠ nucleophile; Glu = proton acceptor) and general methyltransferase mechanism knowledge to select D over A. No protein-specific database lookup is strictly required."
  },
  "case_id": "active_site_0080",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C9",
      "H4",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation for E0D208 (Methyltransferase GfsG) explicitly lists an Active site at position 146 described as 'Proton acceptor' with experimental evidence (ECO:0000305|PubMed:26630077), corroborated by mutagenesis studies of Glu-146, His-150, and Asp-175. The sequence at position 146 is Glu (E), consistent with a proton-acceptor role in methyltransferase catalysis. Choices B (position 286) and C (position 957) are impossible since the protein is only 278 residues long. Choice A (position 112, Nucleophile) does not correspond to any annotated active site feature."
  },
  "important_caveats": [
    "The UniProt annotation for the active site carries evidence code ECO:0000305 (inferred from PubMed:26630077 mutagenesis data), meaning it is experimentally informed but the 'Proton acceptor' label itself is a curator-assigned functional description rather than a directly measured quantity.",
    "The reviewer-only evidence confirms the sequence match (SHA-256 identical across current and historical entries), so the annotation applies to the exact sequence provided.",
    "The protein is classified as EC 2.1.1.- (unspecified methyltransferase); the exact substrate and reaction are not fully characterized, but the Glu-146 proton-acceptor role is supported by mutagenesis data."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B and C are eliminated by sequence length. A is eliminated because position 112 is Arg, which is not a nucleophile, and methyltransferase mechanisms do not feature an enzyme-side nucleophile at that position. Only D is consistent with both the residue identity (Glu) and the catalytic mechanism."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0080",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation for E0D208 (Methyltransferase GfsG) explicitly lists an Active site at position 146 described as 'Proton acceptor' with experimental evidence (ECO:0000305|PubMed:26630077), corroborated by mutagenesis studies of Glu-146, His-150, and Asp-175. The sequence at position 146 is Glu (E), consistent with a proton-acceptor role in methyltransferase catalysis. Choices B (position 286) and C (position 957) are impossible since the protein is only 278 residues long. Choice A (position 112, Nucleophile) does not correspond to any annotated active site feature.",
    "evidence_ids": ["C5", "C9", "H4", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Three independent reasoning steps distinguish the answer: (1) The protein is 278 residues long, so positions 286 (B) and 957 (C) are physically impossible and can be eliminated by arithmetic. (2) Reading the sequence, position 112 is Arginine (R), which is not a catalytic nucleophile in any common enzyme mechanism; its side-chain guanidinium group is protonated at physiological pH and serves structural/binding roles. Position 146 is Glutamate (E), a classic proton acceptor. (3) The SAM-binding motif (VLDVGCGVG at ~positions 74–82) identifies this as a methyltransferase; in O/C-methyltransferase catalysis, a Glu or Asp proton acceptor deprotonates the substrate hydroxyl to generate the nucleophile that attacks the methyl group of SAM. The enzyme residue itself is not the nucleophile—the substrate is. Thus 'Proton acceptor at a Glu' is mechanistically consistent, while 'Nucleophile at an Arg' is not.",
    "missing_item_specific_fact": "None critical. The specific position number (146) could be identified by locating the Glu within the SAM-binding region, but the functional description 'Proton acceptor' vs 'Nucleophile' and the residue identity at each position are derivable from the sequence plus general biochemistry.",
    "reason": "The model can eliminate two choices by protein length, then use amino-acid chemistry (Arg ≠ nucleophile; Glu = proton acceptor) and general methyltransferase mechanism knowledge to select D over A. No protein-specific database lookup is strictly required."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B and C are eliminated by sequence length. A is eliminated because position 112 is Arg, which is not a nucleophile, and methyltransferase mechanisms do not feature an enzyme-side nucleophile at that position. Only D is consistent with both the residue identity (Glu) and the catalytic mechanism."
  },
  "important_caveats": [
    "The UniProt annotation for the active site carries evidence code ECO:0000305 (inferred from PubMed:26630077 mutagenesis data), meaning it is experimentally informed but the 'Proton acceptor' label itself is a curator-assigned functional description rather than a directly measured quantity.",
    "The reviewer-only evidence confirms the sequence match (SHA-256 identical across current and historical entries), so the annotation applies to the exact sequence provided.",
    "The protein is classified as EC 2.1.1.- (unspecified methyltransferase); the exact substrate and reaction are not fully characterized, but the Glu-146 proton-acceptor role is supported by mutagenesis data."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `E0D208` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 28. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:56.118083+00:00.  

```json
{"description":"Proton acceptor","evidences":[{"evidenceCode":"ECO:0000305","id":"26630077","source":"PubMed"}],"location":{"end":{"modifier":"EXACT","value":146},"start":{"modifier":"EXACT","value":146}},"type":"Active site"}
```

Source SHA-256: `85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0`.

### Evidence C9

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)  
**Locator:** `/references/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:56.118083+00:00.  

```json
{"citation":{"authors":["Kudo F.","Kawamura K.","Furuya T.","Yamanishi H.","Motegi A.","Komatsubara A.","Numakura M.","Miyanaga A.","Eguchi T."],"citationCrossReferences":[{"database":"PubMed","id":"26630077"},{"database":"DOI","id":"10.1002/cbic.201500533"}],"citationType":"journal article","firstPage":"233","id":"26630077","journal":"ChemBioChem","lastPage":"238","publicationDate":"2016","title":"Parallel Post-Polyketide Synthase Modification Mechanism Involved in FD-891 Biosynthesis in Streptomyces graminofaciens A-8890.","volume":"17"},"referenceComments":[{"type":"STRAIN","value":"A-8890"}],"referenceNumber":5,"referencePositions":["FUNCTION","CATALYTIC ACTIVITY","POSSIBLE ACTIVE SITE","BIOPHYSICOCHEMICAL PROPERTIES","PATHWAY","DISRUPTION PHENOTYPE","MUTAGENESIS OF GLU-146; HIS-150 AND ASP-175"]}
```

Source SHA-256: `85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)  
**Locator:** `lines 43-53`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:28:00.650050+00:00.  

```text
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, POSSIBLE ACTIVE SITE, BIOPHYSICOCHEMICAL
RP   PROPERTIES, PATHWAY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-146;
RP   HIS-150 AND ASP-175.
RC   STRAIN=A-8890;
RX   PubMed=26630077; DOI=10.1002/cbic.201500533;
RA   Kudo F., Kawamura K., Furuya T., Yamanishi H., Motegi A., Komatsubara A.,
RA   Numakura M., Miyanaga A., Eguchi T.;
RT   "Parallel Post-Polyketide Synthase Modification Mechanism Involved in FD-
RT   891 Biosynthesis in Streptomyces graminofaciens A-8890.";
RL   ChemBioChem 17:233-238(2016).
```

Source SHA-256: `b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)  
**Locator:** `lines 107-109`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:28:00.650050+00:00.  

```text
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:26630077"
```

Source SHA-256: `b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 80. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
